Serum glutathione reductase (NADPH:CSSG oxidoreductase, EC. 1.6.4.2 ( G R ) I has been examined i n cystic fibrosis subjects (CF), obligate C F heterozygotes, and control subjects. Serum protein concentration was similar i n the three groups. Regardless o f the units used to express activitv i milligrams o f protein or milliliters of serum) or whether or not samples were dialyzed against water or phosphate buffer, mean serum GR in C F was greater than in control subjects ( P 5 0.002) in all series over several years. Under the above assay conditions no difference in serum CR between control subjects and carriers was detected. Calculated and assayed values of combined control and C F sera agreed as did expected and observed 50% activity i n 1:2 sera dilutions i n CF, control subjects, and carriers. Addition o f F A D to incubation media did not effect enzvme activity i n the three groups. Differences between C F and control subjects persisted after dialysis in membranes permitting passage of molecules of approximately 12,000 mol wt or less. These findings would tend to exclude the effect of extraneous serum factors in explaining the differences between C F and control subjects. The percentage of initial GR activity after four days storage (0-4") was significantly greater i n C F than i n control subjects ( P < 0.025).
The effect of heparin on serum GR was recorded as the percentage of activity after incubation with heparin vs. activity in the standard assay for individual subjects. The effect of incubation with 5 @g/ml '=?parin on serum GR activity was greater i n control subjects than i n carriers ( P < 0.0005) and C F i P < 0.0005). Mean serum GR activity i n C F and carriers was unaffected by heparin, whereas mean activity i n control subjects was decreased. I n no control was the percentage o f initial activity with heparin greater than the mean o f C F and carrier groups. Only 3 o f 20 C F and 4 o f 20 carrier individuals had percentages lower than the control mean. The C F and carrier distributions were clearlv different from the control distribution. Serum GR was determined i n seven non-CF individuals with chronic obstructive pulmonary disease ( C O P D ). Activity in the C O P D was different from C F and no different from control subjects. I n none of these controls or C O P D was serum GR as great as the C F mean. Serum GR in no C F was as low as the mean o f control subjects or COPD. I t is concluded that serum GR activity is greater i n C F than in control subjects, carriers, and non-CF C O P D subjects; that the difference i n activity is not attributable to an extraneous serum factor, that the activity difference is not secondary to chronic respiratory disease; that i n comparison with control subjects, GR from C F serum behaves differently after storage; and that serum GR from C F and carriers behaves differently from control GR i n the presence o f heparin.
Speculation
Abnormal activity o f glutathione reductase may be fundamentally related to the pathogenesis of cystic fibrosis.
Despite numerous studies (7) . the abnormal gene product in cystic fibrosis (CF) and hence its molecular basis is not yet known. The generally held view of C F pathogenesis concerns an abnormel transport of ions and other small molecules in exocrine tissues (8) . Because enzyme systems of the pentose phosphate pathway are localized at sites of ion transport in salivary glands and other tissues (1 1. 12), we examined this system in CF. In red blood cells (RBC's) mean glucose-6-phosphate dehydrogenase (D-glucose-6-phosphate:NADP oxidoreductase. EC. 1.1.1.49) activity was increased and the mean ratio of NADPH to NADPi was decreased in C F in comparison with age-and sex-matched controls (13) . G R of RBC's may be considered part of the pentose phosphate pathway because of its relative specificity for NADPH (2) . Therefore the G R system was examined. RBC G R activity and total glutath~one (GSSG + G S H ) were increased in C F in comparison with controls (15) . No abnormalities of RBC indices or constants in C F subjects were found (15) that would account for these data. Since characteristic biologic properties of body fluids in carriers for the condition and in C F patients have been reported (7), we decided to assay serum G R activity in C F patients, age-and sex-matched control subjects, and obligate heterozygotes for C F . In the course of these studies we have noted consistent differences in serum G R between C F and control subjects. We now report findings concerning serum GR activity, serum protein concentration; serum G R activity after storage. exposure to heparin and to FAD; effects of dialysis. of combining C F and control serum, and of dilutions on GR activity in C F subjects, carriers and control subjects. Serum G R has been determined also in a group of non-CF patients with COPD.
METHODS
Diagnosis of C F was based on elevated sweat chloride tests and clinical findings. All C F patients were ambulatory. Obligate heterozygotes were parents of C F children. Ten to 30 cc venous blood were obtained from each subject. Sera were collected after 1 hr and stored at 0-4'. Serum G R activity was determined at 25' on duplicate 0.2-ml aliquots of serum (except when the effect of dilution was examined) from the decrease in optical density at 340 nm resulting from oxidation of NADPH to NADP+ by G R in the presence of GSSG (5) . One unit G R activity is defined as that amount of enzyme which reduces I pmol GSSG in I hr at assay temperature. In more recent studies, enzyme activity was determined at 37' with preincubation of all reagents at this temperature. Serum enzyme activity was recorded usually as units per ml serum. In an additional series enzyme activity was expressed as GR units per mg serum protein using the Lowry procedure (9).
Aliquots of serum from an additional nine C F , nine carriers. and nine control subjects were assayed for GR: ( I ) after'dialysis overnight against 0.067 M phosphate buffer, pH 6.6, 4", (2) after dialysis overnight against distilled-deionized water at 4O, and (3) without dialysis. Each dialysis bag containing 2 cc serum was placed in 5-6 liters of buffer or water. According to the supplier the dialysis tubing used retains molecules of molecular weight nreater than 12,000 (16).
Samples were routinely stored overnight in a refrigerator before assay. As a test of storage stability assays were performed also 4 days after collection having been stored at 0-4' and activity compared with initial activity for each individual sample.
It has been reported that heparin inhibits serum G R activity (6). Therefore, three sets of pooled serum samples of CF. carriers. and control subjects were assayed at 37O in duplicate for G R after 5 rnin of preincubation with all reagents except GSSG in the presence of 0, 1, 5, 10. 25, and 100 pg/ml heparin. Each pooled sample consisted of five individuals. Results from the analyses of these samples indicated that the greatest difference between carrier and control serum G R activity occurred in the presence of 5 ~g / m l heparin. Therefore. serum from 20 CF. 18 control. and 20 carrier individuals was assayed with 5 pg/ml heparin and without heparin under the above assay conditions. G R activity was determined in whole sera and in sera diluted 1:2 with buffer used in the assay reaction. Portions of sera from 15 pairs of C F and control samples were combined in I: I ratios. Each sample was assayed individually. Calculated and assayed averages were compared. Assay mixtures containing all components for serum G R determination except GSSG but in addition 0, 1. or 10 pg FAD, were incubated at 37' for 15 min. G R activity was then determined by the usual procedure after addition of GSSG. The effect of F A D was tested in five controls, six CF. and six carriers.
Finally, G R was determined in serum obtained from seven individuals suffering from COPD: agarnmaglobulinernia with
. chronic upper respiratory infection and cough (t7 = , I). and asthma ( n = I) and compared with I2 C F and 12 control subjects. Serum from these subjects was dialyzed overnipht against distilled-deionized water as described above.
RESULTS

I
In all series over several years. serum GR activity was greater in C F subjects in comparison with age-and sex-matched control subjects. No difference between control subjects and carriers was 1 noted (Table I) . In order to determine whether differences were due to increased concentration of serum proteins in C F we assayed milligrams of protein per ml serum in a sample of subjects. No differences among CF, carriers, or control subjects for serum protein concentration were detected: [milligrams protein per ml serum C F = 80.4 * 1.9 (n = 14). control subjects = 77.1 2.3 ( n = 12). carriers = 79.1 * 2.5 (ti = 13)]. Serum G R was assayed in a , portion of the individuals in whom serum protein determinations were made and calculated in units of G R per ml protein. Using these units G R activity was again greater in C F in comparison with control subjects (P < 0.02). Carriers were not different from control subjects. In the additional series of nine CF, nine carriers. and nine control subjects, the mean serum G R in the C F sample I was greater than in control subjects regardless of units used in both , dialyzed and nondialyzed aliquots ( P 5 0.002) (Fig. 1 ) . The mean value of G R activity after 4 days of storage in comparison with initial activity was significantly greater in C F than in control subjects (Table 2) . Mean values from both control and carrier samples retained initial activity. Mean activity in C F was increased after storage.
The pattern of effect of various concentrations of heparin was different in pooled serum samples from CF. carriers, and control subjects (Fig. 2) . Since separation of C F and carriers from control subjects appeared t o be greatest at heparin concentrations of 5 pg/ml we tested the effect of preincubation of serum from individuals with this concentration. The study was repeated on two groups with more than a year intervening between them. Findings in both series were similar and are combined in Table 2 . Differences in percentaze of activity with heparin in comparison with no heparin between C F and carriers on the one hand and control subjects on the other were statistically highly significant. Overlap among individuals in the three groups occurred. but as can be seen in Figure 3 
Assayed values from 7 individuals suffering from C O P D
together with values from an additional I2 C F subjects and I2 control subjects are plotted in Figure 4 . Clearly, serum G R activity in the C O P D patients was different from that in C F and was similar to serum G R activity in control subjects. In none of the control subjects or non-CF C O P D subjects was serum G R as great as the C F mean. Serum G R in no C F subject was as low as the mean of control subjects or non-CF C O P D subjects. Fig. 4 . Individual serum glutathione reductase (GR) activity assayed at 37" after dialysis against distilled water. Each dot represents the mean of triplicate assays on each individual. Asthma (n = I). chronic obstructive pulmonary disease (COPD) (n = 2). upper respiratory infection and chronic cough ( n = 1). hypogarnmaglobulinemia and COPD (n = I), and agammaglobulinemia and COPD (n = 2). CF: cystic fibrosis.
enzyme protein is altered and expresses different activity under assay conditions. This distinction is an extremely difficult one to resolve. In addition to alterations in molecu+ir structure. enzyme activity differences may reflect the rate of synthesis o r degradation of the enzyme itself; or substrate, cofactor. or product differences:
or extraneous factors such a s inhibitors or activators (4) . The most direct explanation for the increased serum G R in CF may be that the enzyme activity difference is secondary to the disease process and/or therapy. However, several observations suggest to us that such an explanation may be too facile and that in fact G R may be related directly to the basic defect in C F .
The possibility that n serum inhibitor or activator of small molecular size in sera in one or the other groups accounted for the activity differences between C F and control subjects was tested by assaying aliquots of samples dialyzed against both distilled-deionized water and phosphate buffer. The relative difference between C F and control subjects was maintained (Fig. I) . The agreement between calculated and assayed values of combined control and C F sera and agreement between I:2 serum dilutions of 50% activitv in control. carriers. and C F subjects similarly makes unlikely the presence of a critical level of some factor in any one of the groups that would account for the observed activity differences. Beutler (1) reported that hemolyrate G R is enhanced by the addition of FAD. However, no such effect was found here in the serum G R assays in the CF. carrier. or control samples. These data do not exclude the possibility of real increased levels of G R in serum of C F subjects. They appear to rulc out the presence of some molecule that would lead to greater apparent activity in C F serum or decreased activity in control subjects at the time of assay. Moreover. serum G R activity in seven C O P D patients was similar to control subjects. This finding would further tend to rule out factors secondary to obstructive respiratory disease as being responsible for the serum G R differences from normal observed in ,--"
Greater relative activity of serum G R in C F in comparison with controls after storage or exposure to heparin suggests that serum G R in C F behaves differently from that in control subjects. These differences d o not seem to be due to quantitative differences between C F and control subjects since each subject was compared with himself t o determine percentage of initial activity. Greater mean activity after storage of G R in serum of C F subjects coincides with similar results with lymphocyte G R (14) . The relative difference between control subjects and C F subjects after storage in two systems as diverse as white blood cells (WBC's) and serum is remarkably similar. Furthermore. in comparison with control subjects, serum G R in carriers as well as in C F responded differently to heparin. The heparin studies were performed on nondialyzed samples. However, in other experiments we noted no consequence of dialysis on heparin effects on serum G R . Heparin has been reported to reverse ciliostatic activity of C F fluids (3) and to abolish a sodium transport effect after retrograde perfusion of salivary gland ducts by C F fluids (lo). However, an explanation of the relationship between these phenomena and the differential effect of heparin on serum G R in C F and control subjects is premature.
Nothing is known about possible relationships between primary and secondary abnormalities in C F and G R . Therefore. it is premature to assess the relationship of these serum G R findings t o C F . Little is known about the function of G R other than its probable role in the maintenance of cellular-SH groups. G R may be involved in the pathogenesis of C F through such a role and/or its role in NADP' production (13. 15). In any case, the observation of ( I ) repeated differences between C F and control subjects for serum G R activity in addition to (2) earlier findings of G R differences between C F and control subjects in RBC's and WBC's, (3) the different response of G R in C F and control subjects t o storage in serum and WBC's (4) the different response of C F and carriers in comparison with control subjects to heparin and (5) the apparently normal serum G R in C O P D is of interest. The differences noted were statistical; individuals cannot be categorized as C F , carriers, or control subjects in terms of activity or stability of serum G R . Even if the G R molecule in C F is of variant form, and this is far from proven, the absence of discrete differences in enzyme activity between groups is not unexpected. Clearly defined bimodal or trimodal distributions of enzyme activity because of inherited differences which exist in the population are the exception rather than the rule (4) . In light of the usual continuity of enzyme activity anions variants in a population. the inherent complexity of serum. the possible genetic heterogeneity of CF. and the indirectness of enzyme activity as an indicator of genetic differences among individuals, the repeated and statistically highly significant G R differences observed appear striking. These facts suggest to us that G R is implicated in the pathogenesis of C F .
SUMMARY
The mean activity of serum G R has been shown to be greater in C F samples than in controls. N o difference in enzyme activity between carriers and control subjects was detected. These observations were similar when recorded in terms of milliliters of serum or in milligrams of protein. Similar results were obtained after dialysis against water or phosphate buffer. Results from ( I ) combinations of sera from C F and control subjects. (2) dilution of serum from C F , control subjects, and carriers and (3) persistence of differences between C F and control sub.iects after dialysis lead us t o conclude that the differences between C F and control sub.iects were not due to an extraneous serum substance. Serum G R differences between C F and control subjects after storage and differences between C F and carriers on the one hand and control subiects on the other rtfter incubation of serum with h e~n r i n sugiest that G R behaves differently in C F . Serum GR activity in seven individuals with chronic obstructive pulmonary disease did not differ from control subjects. These findings suggest to u \ that G R is involved in the pathogenesis of C F .
